| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3282820 | Clinical Gastroenterology and Hepatology | 2013 | 6 Pages |
Abstract
In a large cohort study of patients who received methotrexate monotherapy after thiopurine therapy for CD, 47% continued to receive the therapy or intentionally discontinued successful therapy within 2 years, and 20% did so within 5 years. Long-term use of methotrexate was well tolerated and relatively safe.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Margien L. Seinen, Cyriel Y. Ponsioen, Nanne K.H. de Boer, Bas Oldenburg, Gerd Bouma, Chris J.J. Mulder, Adriaan A. van Bodegraven,